MedPath

To compare the patient own blood product and suturing in terms of skin graft uptake and fixation of ulcer

Phase 4
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2024/01/061810
Lead Sponsor
Pondicherry Institute of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Maximum ulcer area of 100 sq cm

Wagner’s classification grade 1 & 2

Exclusion Criteria

Patients with ß hemolytic streptococcus infection

Patients who were positive for HIV, HBsAg and HCV

Patients with coagulation disorders

Malignant ulcer

Monophasis PVD

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the uptake of skin graft between patients undergoing <br/ ><br>split skin graft with and without Platelet Rich PlasmaTimepoint: This data will be assessed during the post operative period especially during post operative day 3,5 and 7 <br/ ><br>split skin graft with and without Platelet Rich Plasma
Secondary Outcome Measures
NameTimeMethod
Hematoma formationTimepoint: this outcome will be assessed during postoperative period usually 10 days after the procedure
© Copyright 2025. All Rights Reserved by MedPath